HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 107/1/253    most recent 90960.2008v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Vol, A. Articles by Efrati, S. PubMed PubMed Citation Articles by Vol, A. Articles by Efrati, S.

Application of muscle biopotential measurement for sustained, noninvasive blood glucose survey

Research and Development Unit, Assaf Harofeh Medical Center, Zerifin, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Submitted 26 July 2008 ; accepted in final form 5 March 2009

Biopotential, the electric potential generated by living tissues, is affected by changes in extracellular electrolyte and glucose concentrations. We aimed to apply correlation between blood glucose concentrations (BGC) and biopotential of peripheral muscles for noninvasive blood glucose measurement. The study included 58 Wistar rats. In part of them, diabetes was induced by streptozotocin injection. Group 1, comprising 19 normal and 5 diabetic rats, received glucose-challenging protocol (intraperitoneal injection of 1 g/ml glucose). Group 2, 24 normal and 6 diabetic rats, received insulin-challenging protocol (three 30 IU insulin injections with 15-min intervals). Four control rats, group 3, were injected with 2-ml saline. BGC were measured by a standard ACCU-CHEK-Sensor Meter and compared with those estimated by biopotential sensor, further designated as GlucoSat, placed around proximal parts of the tails of the anaesthetized animals. GlucoSat results were calculated using the following biopotential equation: BGC(t) = k1 * F1(t) + k2 * F2(t) * k3 * F3(t) + k4, based on an experimental model involving estimation of pH, muscle metabolism, and tissue conductance, where t is time, k1–k4 are coefficients, and F1–F4 are functions. Mean biopotential system measured BGC was 181.7 ± 4.3 mg/dl, not differing statistically from 187.9 ± 4.3 mg/dl estimated by ACCU-CHEK. Pearson's correlation coefficient (r²) was 0.961 (P < 0.00001), indicating strong, direct correlation between the results. Within the nondiabetic group, r² was 0.944 (P < 0.00001), while, within the diabetic group, r² was 0.974 (P < 0.00001). No significant, adverse skin reactions were concomitantly observed in any experimental group. Biopotential measurements may be used for continuous, noninvasive estimation of changes in BGC. Further studies are needed to evaluate the applicability of this method to humans.

diabetes; biopotential; bioelectricity; muscle metabolism